Recombinant Pongo abelii ADP/ATP translocase 2 (SLC25A5)

How does SLC25A5 function in mitochondrial energy metabolism?

SLC25A5 (also known as ANT2) serves as an ADP/ATP antiporter that mediates the import of ADP into the mitochondrial matrix for ATP synthesis and export of ATP to the cytoplasm to fuel cellular processes . The protein operates through an alternating access mechanism with a single substrate-binding site that is intermittently exposed to either the cytosolic side (c-state) or matrix side (m-state) of the inner mitochondrial membrane .

Beyond its primary nucleotide transport function, SLC25A5 plays a dual role in mitochondrial physiology:

• Energy production: Functions as an ADP/ATP antiporter to support ATP synthesis

• Thermogenesis: Acts as a proton transporter that uncouples electron transport from ATP synthesis

This dual functionality positions SLC25A5 as a master regulator of mitochondrial energy output, maintaining a delicate balance between ATP production and thermogenesis . The proton transporter activity requires free fatty acids as cofactors but does not transport them directly .

What are the optimal storage and handling conditions for recombinant SLC25A5?

For maximum stability and activity of recombinant Pongo abelii SLC25A5, observe the following storage and handling protocols:

The protein is typically supplied in a Tris-based buffer containing 50% glycerol, optimized to maintain stability . Repeated freezing and thawing cycles should be strictly avoided as they lead to protein denaturation and activity loss . For experimental work spanning multiple days, prepare small working aliquots to minimize freeze-thaw cycles.

When diluting the protein for experiments, maintain a minimum glycerol concentration of 10% to preserve stability, unless the experimental protocol specifically requires lower concentrations .

How can researchers effectively study SLC25A5's role in mitochondrial permeability transition pore (mPTP) formation?

SLC25A5 plays a key role in mPTP activity, which enables the passage of molecules up to 1.5 kDa across mitochondrial membranes during cellular stress . To investigate this function, researchers can employ several methodological approaches:

• Genetic manipulation approaches:

  • Generate stable knockdown/knockout cell lines using siRNA or CRISPR/Cas9 technology

  • Perform rescue experiments with wild-type or mutated recombinant SLC25A5

  • Create chimeric proteins to identify domains involved in mPTP regulation

• Functional assays:

  • Calcium retention capacity measurements in isolated mitochondria

  • Mitochondrial swelling assays monitoring absorbance changes at 540 nm

  • Cytochrome c release quantification by ELISA or Western blotting

  • Membrane potential assessment using potentiometric dyes (TMRM, JC-1)

• Structural approaches:

  • Reconstitution of purified SLC25A5 into liposomes or nanodiscs

  • Cross-linking with bifunctional reagents to identify interaction partners

  • Blue native PAGE to identify native protein complexes

These complementary approaches can address the fundamental question of whether SLC25A5 constitutes a pore-forming component of mPTP or functions as a regulatory protein .

How is SLC25A5 involved in adipogenesis regulation, and what experimental approaches can reveal its mechanism?

Recent research has identified SLC25A5 as a significant regulator of adipogenesis . Transcriptomic and lipidomic analyses revealed that SLC25A5 expression is significantly upregulated during adipogenic differentiation in mouse models . Experimental evidence demonstrates that:

• Depletion effects: SLC25A5 knockdown leads to:

  • Suppressed expression of adipogenesis-related genes

  • Reduced triglyceride accumulation

  • Inhibited PPARγ protein expression

  • Decreased oxidative phosphorylation protein expression (ATP5A1, CQCRC2, MTCO1)

  • Reduced ATP production

• Signaling pathway involvement: The adipogenic differentiation inhibition appears to be mediated through ERK1/2 phosphorylation, confirmed through intervention with PD98059 (an ERK1/2 inhibitor)

To investigate this mechanism, researchers can employ the following protocol:

Protocol for studying SLC25A5 in adipogenesis:

a) Cell culture preparation:

• Culture preadipocytes (e.g., OP9 cells or adipose-derived stem cells) to 50-70% confluence

• Transfect with SLC25A5 siRNA (10 nM) or negative control siRNA using appropriate transfection reagent

• Incubate for 24 hours before replacing media with adipogenic differentiation medium

b) Analytical methods:

• Oil Red O staining to visualize and quantify lipid accumulation

• Western blotting for adipogenic markers (PPARγ) and OXPHOS proteins

• RT-qPCR to measure expression of adipogenesis-related genes

• ATP production assays to assess metabolic effects

• ERK pathway analysis using phospho-specific antibodies

This research suggests SLC25A5 could represent a novel therapeutic target for obesity treatment through its role in regulating adipogenesis .

What roles does SLC25A5 play in respiratory epithelium, and how can it be studied in airway disease models?

SLC25A5 (ANT2) has been identified as a protective factor in airway epithelial metabolism, particularly in the context of cigarette smoke exposure and chronic obstructive pulmonary disease (COPD) . Gene expression studies show ANT2 is reduced in lung tissue from COPD patients and in mouse smoking models .

Research demonstrates that overexpression of ANT proteins results in:

• Enhanced oxidative respiration and ATP flux

• Stimulated airway surface hydration by ATP

• Maintained ciliary beating after exposure to cigarette smoke

In addition to mitochondrial localization, ANT proteins have been found at the plasma membrane in airway epithelial cells, suggesting a direct role in regulating airway homeostasis .

Experimental approaches for studying SLC25A5 in airway models:

• Cell models:

  • Primary human bronchial epithelial cells

  • Air-liquid interface cultures to mimic physiological conditions

  • Exposure to cigarette smoke extract to model environmental stress

• Functional assays:

  • Ciliary beat frequency measurement using high-speed video microscopy

  • Airway surface liquid height assessment

  • ATP release quantification using luciferase-based assays

  • Mitochondrial respiration analysis using Seahorse XF technology

• In vivo models:

  • Transgenic mice with altered SLC25A5 expression

  • Cigarette smoke exposure models

  • Measurement of respiratory parameters and ciliary function

This research highlights the potential for SLC25A5 upregulation or agonist development as a therapeutic strategy for protecting against dysfunctional mitochondrial metabolism, impaired airway hydration, and reduced ciliary motility in COPD .

How does SLC25A5 differ functionally from other members of the SLC25 family, particularly SLC25A4?

The SLC25 family encompasses multiple adenine nucleotide translocases with distinct tissue distribution and specialized functions. Comparative analysis of SLC25A5 (ANT2) and SLC25A4 (ANT1) reveals both shared mechanisms and unique properties:

Both proteins function as ADP/ATP antiporters and proton transporters, contributing to a balance between energy production and thermogenesis . They both interact with TIMM44 to promote mitophagy by inhibiting the presequence translocase TIMM23, thereby stabilizing PINK1 .

The existence of multiple ANT isoforms (SLC25A4, SLC25A5, SLC25A6, and SLC25A31) across species suggests evolutionary adaptation to specific tissue requirements and cellular contexts .

What are the technical considerations for comparing human and Pongo abelii SLC25A5 in functional studies?

• Sequence comparison:

  • Human SLC25A5 (UniProtKB/Swiss-Prot: P05141)

  • Pongo abelii SLC25A5 (UniProt NO.: Q5R5A1)

  • Alignment analysis to identify conserved and divergent regions

• Expression system selection:

  • Human SLC25A5 is commonly expressed in HEK-293 cells

  • Recombinant Pongo abelii SLC25A5 can be expressed in various systems including HEK-293 cells

  • Use the same expression system for both proteins to minimize system-dependent variations

• Tag considerations:

  • Standardize tag type and position (N-terminal vs. C-terminal)

  • Verify that tags do not interfere with protein function

  • Consider tag-free proteins for certain applications

• Functional assay standardization:

  • Use identical buffer conditions, substrate concentrations, and assay parameters

  • Include internal controls to normalize for experimental variations

  • Perform biological and technical replicates to ensure reproducibility

• Species-specific factors:

  • Consider potential differences in post-translational modifications

  • Account for species-specific interaction partners

  • Evaluate temperature sensitivity if applicable

By standardizing these experimental variables, researchers can make valid comparisons between human and Pongo abelii SLC25A5, providing insights into evolutionary conservation and species-specific adaptations of this important mitochondrial carrier.

How can SLC25A5 be utilized in studying mitochondrial uncoupling mechanisms?

SLC25A5 plays a crucial role in mitochondrial uncoupling, a process that dissipates the proton gradient to generate heat instead of ATP . This function positions SLC25A5 as a valuable tool for investigating thermogenesis in tissues that do not express the canonical uncoupling protein UCP1 .

Experimental approaches for studying mitochondrial uncoupling through SLC25A5:

• Bioenergetic analysis:

  • Oxygen consumption measurements in isolated mitochondria or intact cells

  • Simultaneous monitoring of oxygen consumption and extracellular acidification

  • Assessment of coupling efficiency and spare respiratory capacity

  • Proton leak measurements under various substrate conditions

• Structure-function studies:

  • Site-directed mutagenesis to identify residues critical for proton transport

  • Domain swapping with other SLC25 family members

  • Investigation of fatty acid binding sites and their role in uncoupling

• Regulatory mechanisms:

  • Analysis of how ADP/ATP antiporter activity inhibits proton transporter function

  • Identification of post-translational modifications affecting this balance

  • Screening for small molecules that modulate the switch between functions

• Thermogenesis assessment:

  • Direct temperature measurements in cellular models

  • Infrared thermography for spatial resolution of heat production

  • Calorimetric approaches in cellular systems

These methodologies can help elucidate how SLC25A5 maintains the balance between ATP production and thermogenesis, potentially leading to therapeutic approaches for metabolic disorders .

What methodological approaches can resolve the controversy regarding SLC25A5's role in the mitochondrial permeability transition pore?

The precise role of SLC25A5 in mitochondrial permeability transition pore (mPTP) formation remains controversial—whether it constitutes a pore-forming component or functions as a regulatory protein . Resolving this question requires sophisticated methodological approaches:

• Cryo-electron microscopy:

  • High-resolution structural analysis of mPTP complexes

  • Immunogold labeling to localize SLC25A5 within the complex

  • Tomographic reconstruction of membrane architecture during pore opening

• Reconstitution experiments:

  • Purification of SLC25A5 and potential mPTP components

  • Reconstitution into artificial membrane systems

  • Electrophysiological characterization of reconstituted channels

  • Systematic omission of components to determine minimal pore requirements

• Cross-linking and proximity labeling:

  • Chemical cross-linking followed by mass spectrometry

  • BioID or APEX2 proximity labeling to identify proteins in close proximity to SLC25A5 during mPTP activation

  • Fluorescence resonance energy transfer (FRET) to detect conformational changes

• Genetic approaches:

  • Generation of SLC25A5 variants lacking specific domains

  • Creation of conditional knockout models with temporal control

  • CRISPR/Cas9 gene editing to introduce specific mutations at endogenous loci

• Real-time imaging techniques:

  • Super-resolution microscopy to visualize dynamic changes in mPTP components

  • Correlation of structural changes with functional parameters

  • Live-cell imaging with genetically encoded sensors for calcium, ROS, and membrane potential

By integrating these approaches, researchers can develop a comprehensive understanding of SLC25A5's precise contribution to mPTP formation and regulation, with implications for cell death mechanisms and potential therapeutic interventions .

What are common technical challenges when working with recombinant SLC25A5, and how can they be addressed?

As a mitochondrial membrane protein, SLC25A5 presents several technical challenges that require specific troubleshooting strategies:

• Protein solubility and aggregation issues:

  • Challenge: Hydrophobic regions can cause aggregation in aqueous buffers

  • Solution: Include appropriate detergents (0.1-1% CHAPS, DDM, or digitonin); reconstitute into nanodiscs or liposomes; optimize buffer ionic strength; add stabilizing agents like glycerol (as used in commercial preparations)

• Loss of functional activity:

  • Challenge: Activity loss during purification or storage

  • Solution: Minimize freeze-thaw cycles; store in 50% glycerol as recommended ; avoid oxidizing conditions; include reducing agents; validate activity immediately upon receipt

• Non-specific binding in interaction studies:

  • Challenge: High background in pull-down or co-immunoprecipitation experiments

  • Solution: Use more stringent washing conditions; pre-clear lysates; include appropriate blocking agents; validate interactions with multiple techniques

• Inconsistent expression yields:

  • Challenge: Variable expression levels between batches

  • Solution: Optimize codon usage for expression system; use controlled induction protocols; consider different expression systems (HEK-293, E. coli, CFPS)

• Reproducing physiological conditions:

  • Challenge: Creating an environment that mimics the mitochondrial inner membrane

  • Solution: Use artificial membrane systems with appropriate lipid composition; include physiological concentrations of ions and substrates; account for membrane potential in experimental design

By anticipating these challenges and implementing appropriate solutions, researchers can significantly improve the quality and reproducibility of experiments involving recombinant SLC25A5.

How can researchers validate the functionality of recombinant Pongo abelii SLC25A5 for experimental use?

Before employing recombinant Pongo abelii SLC25A5 in complex experimental setups, researchers should validate its functionality through a systematic approach:

Validation protocol for recombinant SLC25A5:

• Protein quality assessment:

  • SDS-PAGE to confirm molecular weight (approximately 33 kDa plus tag size)

  • Western blotting with specific antibodies

  • Mass spectrometry to verify sequence integrity

  • Size exclusion chromatography to assess oligomeric state

• ADP/ATP transport activity:

  • Reconstitution into liposomes loaded with either ADP or ATP

  • Measurement of nucleotide exchange using radiolabeled or fluorescent substrates

  • Determination of transport kinetics (Km, Vmax)

  • Inhibition studies with known ANT inhibitors (atractyloside, bongkrekic acid)

• Secondary function validation:

  • Assessment of proton transport capability

  • Measurement of calcium-induced mitochondrial swelling

  • Evaluation of membrane potential changes in reconstituted systems

• Comparative benchmarking:

  • Parallel testing with commercially available standards

  • Comparison with human SLC25A5 under identical conditions

  • Verification against published functional parameters

• Downstream application testing:

  • Small-scale pilot experiments for intended applications

  • Positive and negative controls to establish dynamic range

  • Dose-response relationships to determine optimal working concentrations